Schroetter Syndrome: Effort-Induced Upper Extremity DVT Explained
Indunil Karunarathna, Founder of Uva Clinical Research Lab (UCRL), posted on LinkedIn:
”Schroetter Syndrome Effort Induced Upper Extremity Deep Vein Thrombosis
Paget-Schroetter syndrome (PSS), also known as “effort thrombosis,” represents a primary form of upper extremity deep vein thrombosis (UEDVT) typically arising in young, healthy, and active individuals following strenuous or repetitive upper limb exertion.
Recognized as the venous subtype of thoracic outlet syndrome (TOS), PSS occurs due to mechanical compression of the subclavian vein within the costoclavicular space, often potentiated by structural anomalies such as cervical ribs, hypertrophied scalene muscles, or aberrant ligamentous insertions. The pathophysiology integrates Virchow’s triad, with endothelial trauma, venous stasis, and hypercoagulability converging to precipitate thrombosis.
Clinically, PSS presents with sudden upper extremity swelling, pain, heaviness, and cyanosis, often following athletic or occupational activity. Diagnosis requires high clinical suspicion and confirmation with duplex ultrasonography, venography, or advanced cross-sectional imaging, while laboratory investigations may identify concomitant thrombophilic disorders.
Management strategies emphasize multimodal therapy: immediate anticoagulation, catheter-directed thrombolysis (CDT) or pharmacomechanical thrombectomy for clot clearance, and surgical thoracic outlet decompression to correct the underlying anatomical cause. Long-term outcomes are optimized by interdisciplinary collaboration involving vascular surgeons, radiologists, internists, and rehabilitation specialists.
Despite advances in endovascular and surgical techniques, controversies remain regarding timing of decompression, duration of anticoagulation, and management of chronic venous occlusion. With appropriate treatment, recanalization rates of 75–90% are achievable, preventing long-term complications such as recurrent thrombosis, pulmonary embolism, and postthrombotic syndrome.
Future research should focus on refining minimally invasive strategies, optimizing patient selection for surgical intervention, and developing preventive approaches for high-risk athletic populations.”
Read the full article here.
Author: Indunil Karunarathna
Stay updated with Hemostasis Today.
-
Oct 13, 2026, 15:51Merel Timmer: Hemophilia Twinning Partnership Strengthens Care and Quality of Life in Indonesia
-
Oct 13, 2026, 15:41Sarah Alam: ASH 2026 Guidelines on Iron Deficiency Diagnosis and Updated Ferritin Thresholds
-
Oct 13, 2026, 15:35Jamie Elmawieh: Prophylactic Anticoagulation Improves Survival in Isolated Tumor Thrombus
-
Oct 13, 2026, 15:30Sally Mandour: Methemoglobinemia When Hemoglobin Cannot Carry Oxygen
-
Oct 13, 2026, 15:21Renel Tique: Advancing Hemophilia Care Through Global Collaboration and Clinical Innovation
-
Oct 13, 2026, 15:08Anastasia Chatzistamati: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome
-
Oct 13, 2026, 15:08Yousma Khan: Hematology Practical Series Day 11 Reticulocyte Count and Its Role in Anemia Diagnosis
-
Oct 13, 2026, 14:56Manal Rayyan: Multidisciplinary Collaboration in Rare Bleeding Disorders – Reflections from Abu Dhabi
-
Oct 13, 2026, 14:54Kalyan Roy: Understanding Blood Transfusion Sets for Safe Clinical Administration